Cite
HARVARD Citation
Bode, B. et al. (n.d.). Long‐term efficacy and safety of canagliflozin over 104 weeks in patients aged 55–80 years with type 2 diabetes. Diabetes, obesity & metabolism. 17 (3), pp. 294-303. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bode, B. et al. (n.d.). Long‐term efficacy and safety of canagliflozin over 104 weeks in patients aged 55–80 years with type 2 diabetes. Diabetes, obesity & metabolism. 17 (3), pp. 294-303. [Online].